OptimizeRx Corp (OPRX) stock
OPRXNasdaqServices-Business Services, NECFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 11/3030% below fair value
$7.34−1.53 (-17.25%)
Close on Nov 13, 2026Market cap $138.26MP/E 28.2Yield –
OptimizeRx gross margin
Gross margin is gross profit as a percentage of revenue.
OptimizeRx's gross margin for the twelve months ending Sep 30, 2026 was 75.3%. For fiscal 2025 it was 67.3%, against 64.5% the year before. The highest annual figure on record is 94.2% in fiscal 2012.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 67.3% | +2.8 |
| FY2024 | Dec 31, 2024 | 64.5% | +4.5 |
| FY2023 | Dec 31, 2023 | 60.0% | −2.4 |
| FY2022 | Dec 31, 2022 | 62.4% | +4.3 |
| FY2021 | Dec 31, 2021 | 58.1% | +2.5 |
| FY2020 | Dec 31, 2020 | 55.7% | −7.1 |
| FY2019 | Dec 31, 2019 | 62.8% | +5.2 |
| FY2018 | Dec 31, 2018 | 57.6% | +8.5 |
| FY2017 | Dec 31, 2017 | 49.1% | −6.9 |
| FY2016 | Dec 31, 2016 | 56.0% | +6.2 |
| FY2015 | Dec 31, 2015 | 49.8% | −0.6 |
| FY2014 | Dec 31, 2014 | 50.5% | −9.8 |
| FY2013 | Dec 31, 2013 | 60.2% | −34.0 |
| FY2012 | Dec 31, 2012 | 94.2% | – |
Quarterly gross margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | 75.2% | +8.0 |
| Q2 FY2026 | Jun 30, 2026 | 76.5% | +12.7 |
| Q1 FY2026 | Mar 31, 2026 | 75.2% | +14.4 |
| Q4 FY2025 | Dec 31, 2025 | 74.8% | +6.6 |
| Q3 FY2025 | Sep 30, 2025 | 67.2% | +4.1 |
| Q2 FY2025 | Jun 30, 2025 | 63.8% | +1.6 |
| Q1 FY2025 | Mar 31, 2025 | 60.9% | −1.1 |
| Q4 FY2024 | Dec 31, 2024 | 68.1% | +5.3 |
| Q3 FY2024 | Sep 30, 2024 | 63.1% | +3.1 |
| Q2 FY2024 | Jun 30, 2024 | 62.2% | +5.6 |
| Q1 FY2024 | Mar 31, 2024 | 62.0% | +4.8 |
| Q4 FY2023 | Dec 31, 2023 | 62.9% | −0.5 |
| Q3 FY2023 | Sep 30, 2023 | 60.0% | +1.0 |
| Q2 FY2023 | Jun 30, 2023 | 56.6% | −4.4 |
| Q1 FY2023 | Mar 31, 2023 | 57.2% | +0.9 |
| Q4 FY2022 | Dec 31, 2022 | 63.4% | +4.3 |
| Q1 FY2022 | Mar 31, 2022 | 59.0% | +4.5 |
| Q4 FY2021 | Dec 31, 2021 | 61.0% | +8.6 |
| Q3 FY2021 | Sep 30, 2021 | 56.3% | −0.9 |
| Q2 FY2021 | Jun 30, 2021 | 59.0% | +0.5 |
| Q1 FY2021 | Mar 31, 2021 | 54.5% | −2.7 |
| Q4 FY2020 | Dec 31, 2020 | 52.4% | −9.3 |
| Q3 FY2020 | Sep 30, 2020 | 57.2% | −12.4 |
| Q2 FY2020 | Jun 30, 2020 | 58.6% | −3.6 |
| Q1 FY2020 | Mar 31, 2020 | 57.3% | −0.8 |
| Q2 FY2019 | Jun 30, 2019 | 61.6% | +5.5 |
| Q1 FY2019 | Mar 31, 2019 | 69.6% | +18.4 |
| Q4 FY2018 | Dec 31, 2018 | 62.2% | −0.8 |
| Q3 FY2018 | Sep 30, 2018 | 58.1% | +13.0 |
| Q2 FY2018 | Jun 30, 2018 | 56.1% | +12.2 |
| Q1 FY2018 | Mar 31, 2018 | 51.2% | +15.4 |
| Q4 FY2017 | Dec 31, 2017 | 63.0% | +1.0 |
| Q3 FY2017 | Sep 30, 2017 | 45.1% | −14.4 |
| Q2 FY2017 | Jun 30, 2017 | 44.0% | −7.8 |
| Q1 FY2017 | Mar 31, 2017 | 35.8% | – |
| Q4 FY2016 | Dec 31, 2016 | 61.9% | – |
| Q3 FY2016 | Sep 30, 2016 | 59.5% | – |
| Q2 FY2016 | Jun 30, 2016 | 51.8% | – |
See a number that looks wrong?